Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006Mothaffar F Rimawi, Ingrid A Mayer, Andres Forero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone MetastasisZahi Mitri, Rita Nanda, Kimberly Blackwell, et al.
Journal of the National Cancer Institute|January 7, 2026
Breast cancer recurrence and mortality among survivors of childhood cancerCindy Im, Hasibul Hasan, Aparna Srinivasan, et al.
Breast Cancer Research and Treatment|October 28, 2020
Racial disparities in survival outcomes among breast cancer patients by molecular subtypesFangyuan Zhao, Brenda Copley, Qun Niu, et al.
Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.
Breast Cancer Research and Treatment|September 21, 2024
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapySaya Jacob, Anika Christofferson, Samantha Fisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Therapeutic Advances in Medical Oncology|January 8, 2021
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trialNatalie Reizine, Everett E Vokes, Ping Liu, et al.
Research Square|July 17, 2025
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancerJustin Balko, Xiaopeng Sun, Ann Hanna, et al.
Springerplus|July 8, 2016
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancerRita Nanda, Erica M Stringer-Reasor, Poornima Saha, et al.
Pageof 15